Discontinuing DMTs in Patients with Stable Relapsing-remitting MS: When and How?
Release Date: 11/10/2023
MS Prodrome: Implications and Future Research Directions
The ECTRIMS Podcast
If you talk to someone living with MS about their journey, one of the first things they will tell you is that they knew something was wrong long before they received their diagnosis. While this anecdotal evidence has been commonly discussed, it was only relatively recently that the research world has started to investigate this concept. Through this work, the idea of an MS prodrome has been studied, with potential implications for early diagnosis and treatment. Host Brett Drummond of MSTranslate speaks with Prof. Helen Tremlett of the University of British Columbia, a leading expert in...
info_outline
Episode 37: Future MS Therapeutics
The ECTRIMS Podcast
Significant progress has been made in multiple sclerosis (MS) treatments over the past 20 years. What does the next 20 years hold for MS therapies? What novel targets are being investigated? What clinical trials are in the pipeline and when can we expect new medications in the market? Host Brett Drummond of MS Translate explores these questions and more with Prof. Heinz Wiendl of University of Freiburg and Prof. Ludwig Kappos of University Hospital Basel.
info_outline
MS Nurses at ECTRIMS 2024
The ECTRIMS Podcast
Nurses play a specialised and unique role in the journey of people living with multiple sclerosis (MS). At ECTRIMS 2024, MS nurses showcased their experiences and insights into how to effectively support patients. In this episode, host Brett Drummond of MSTranslate talks with veteran MS nurses K-J Lazarus of Austin Health in Australia and Fiona d'Young of the Auckland Hospital in New Zealand.
info_outline
Patient Community Day Highlights of ECTRIMS 2024: Part II
The ECTRIMS Podcast
The Patient Community Day of ECTRIMS 2024 brought together people living with multiple sclerosis (MS), medical professionals, researchers, and advocates in two interactive sessions. They explored the forefront of MS research and treatment, focusing on groundbreaking topics like remyelination and myelin repair. They disussed promising new therapies that could revolutionise patient care, along with practical lifestyle changes and effective symptom management strategies. In Part II of our Patient Community Day episode, host Brett Drummond of MSTranslate talks to Sumaira Ahmed and Trevis Gleason,...
info_outline
Patient Community Day Highlights of ECTRIMS 2024: Part I
The ECTRIMS Podcast
The Patient Community Day of ECTRIMS 2024 brought together people living with multiple sclerosis (MS), medical professionals, researchers, and advocates in two interactive sessions. They explored the forefront of MS research and treatment, focusing on groundbreaking topics like remyelination and myelin repair. They disussed promising new therapies that could revolutionise patient care, along with practical lifestyle changes and effective symptom management strategies. In Part 1 of our Patient Community Day episode, Elisabeth Kasilingam, Chief Executive Officer of the European Multiple...
info_outline
Episode 36: Advancing MS Knowledge through the ECTRIMS Fellowship
The ECTRIMS Podcast
The recent ECTRIMS 2024 in Copenhagen showcased the work of young scientific investigators, including this year's ECTRIMS Fellowship recipients Oscar Ayala from Colombia and Zuhal Abasiyanik from Turkey. Every year, ECTRIMS awards fellowships across various categories to promote knowledge and expertise in the field of multiple sclerosis (MS). Oscar and Zuhal spoke with host Brett Drummond of MSTranslate about the research projects that they will be pursuing and how they believe this opportunity will impact their career. The ECTRIMS Fellowship application period for the 2025 cycle is now open....
info_outline
Day 3 Highlights of ECTRIMS 2024
The ECTRIMS Podcast
Former ECTRIMS President and MS Journal Editor-in-Chief Alan Thompson and host Brett Drummond wrap up the last day of ECTRIMS 2024 with their final thoughts and insights.
info_outline
Day 2 Highlights of ECTRIMS 2024
The ECTRIMS Podcast
Anne Helme, Head of Research at MSIF, and host Brett Drummond discuss the key takeaways unveiled on the second day of ECTRIMS 2024 in Copenhagen, as well as the value of global collaboration.
info_outline
Day 1 Highlights of ECTRIMS 2024
The ECTRIMS Podcast
ECTRIMS Vice President Bruno Stankoff highlights the most relevant insights from day one of ECTRIMS 2024 in Copenhagen, and provides a glimpse of what to expect from the ECTRIMS society in the coming year.
info_outline
Pre-Day Highlights of ECTRIMS 2024
The ECTRIMS Podcast
Listen to Romain Marignier from CHU de Lyon and host Brett Drummond discuss highlights of ECTRIMS' new Pre-Day on NMOSD, MOGAD, and other rare neurological conditions.
info_outlineLong term use of disease modifying treatments (DMTs) poses challenges in terms of safety and pharmacoeconomics, while preventing disability progression. As such, there is an ongoing debate on how long disease modifying treatments should be continued and if discontinuation should be considered in stable multiple sclerosis.
In this episode, Alan Thompson, Editor in Chief of the MS Journal, speaks with Gilles Edan, Professor of Clinical Neurology and chair of the Department of Neurosciences, University Hospital of Rennes; and Eva Strijbis, neurologist at the Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers.